Identification of a hotspot on PD-L1 for pH-dependent binding by monoclonal antibodies for tumor therapy

Signal Transduct Target Ther. 2020 Aug 24;5(1):158. doi: 10.1038/s41392-020-00254-z.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / chemistry*
  • Antibodies, Monoclonal / therapeutic use
  • B7-H1 Antigen / antagonists & inhibitors
  • B7-H1 Antigen / chemistry*
  • B7-H1 Antigen / genetics
  • Binding Sites / drug effects
  • Humans
  • Immune Checkpoint Inhibitors / chemistry*
  • Immune Checkpoint Inhibitors / therapeutic use
  • Immunotherapy
  • Neoplasms / genetics
  • Neoplasms / immunology
  • Neoplasms / pathology
  • Neoplasms / therapy*
  • Programmed Cell Death 1 Receptor / antagonists & inhibitors
  • Programmed Cell Death 1 Receptor / chemistry*
  • Programmed Cell Death 1 Receptor / genetics
  • Protein Binding / drug effects
  • Protein Conformation / drug effects

Substances

  • Antibodies, Monoclonal
  • B7-H1 Antigen
  • CD274 protein, human
  • Immune Checkpoint Inhibitors
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor